BPC-157 and TB-500 Dosage Protocol BPC-157: 250500mcg daily, injected subcutaneously near the injury site TB-500: 22.5mg twice weekly (loading phase) for 46 weeks, then 2mg once weekly (maintenance phase) The combination is typically used for 612 weeks, depending on injury severity and healing progress
4 Claims about gut disease, injury recovery timelines, or performance in people rest on rodent data, not on human trials
It breaks down the sulfomucins into small organic metabolites that can then be used by hydrogenogenic bacteria, mainly Bacteroidetes and Firmicutes strains, as a source for hydrogen gas production through fermentation (Wolf et al., 2016)
Combined with vitamin C, which supports collagen production, the result is a more even, radiant complexion over a course of treatments
Acute soft tissue injuries represent the sweet spot for BPC-157
For example, zeaxanthin and genistein have been shown to suppress HIF-1 and TGF- related pathways in experimental gastritis and ulcer models, respectively, while oxidative stress has been closely linked to HIF-1 induction in gastric injury (Elhadidy et al